Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications
Top Cited Papers
- 18 August 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 7 (9), 1063-1077
- https://doi.org/10.1517/17425247.2010.502560
Abstract
Importance of the field: Metal oxide nanoparticles, including zinc oxide, are versatile platforms for biomedical applications and therapeutic intervention. There is an urgent need to develop new classes of anticancer agents, and recent studies demonstrate that ZnO nanomaterials hold considerable promise. Areas covered in this review: This review analyzes the biomedical applications of metal oxide and ZnO nanomaterials under development at the experimental, preclinical and clinical levels. A discussion regarding the advantages, approaches and limitations surrounding the use of metal oxide nanoparticles for cancer applications and drug delivery is presented. The scope of this article is focused on ZnO, and other metal oxide nanomaterial systems, and their proposed mechanisms of cytotoxic action, as well as current approaches to improve their targeting and cytotoxicity against cancer cells. What the reader will gain: This review aims to give an overview of ZnO nanomaterials in biomedical applications. Take home message: Through a better understanding of the mechanisms of action and cellular consequences resulting from nanoparticles interactions with cells, the inherent toxicity and selectivity of ZnO nanoparticles against cancer may be improved further to make them attractive new anticancer agents.Keywords
This publication has 127 references indexed in Scilit:
- Near‐Infrared‐Resonant Gold/Gold Sulfide Nanoparticles as a Photothermal Cancer Therapeutic AgentSmall, 2010
- The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine InductionNanoscale Research Letters, 2009
- The role of TNF superfamily members in T-cell function and diseasesNature Reviews Immunology, 2009
- Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imagingBiomaterials, 2008
- The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science ApplicationsAccounts of Chemical Research, 2008
- Preferential killing of cancer cells and activated human T cells using ZnO nanoparticlesNanotechnology, 2008
- Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systemsApplied Physics Letters, 2007
- Nanoparticle Interaction with Biological Membranes: Does Nanotechnology Present a Janus Face?Accounts of Chemical Research, 2007
- Mechanisms of Cell Death in Oxidative StressAntioxidants and Redox Signaling, 2007
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006